13th week of 2012 patent applcation highlights part 49 |
Patent application number | Title | Published |
20120077831 | METHODS AND ASSAYS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME - Methods of treating irritable bowel syndrome (IBS) are disclosed. Assays and kits useful in the treatment of IBS are also disclosed. | 2012-03-29 |
20120077832 | BESYLATE SALT OF A BTK INHIBITOR - The present invention provides a salt form, and compositions thereof, useful as an inhibitor of one or more protein kinases and which exhibits desirable characteristics for the same. | 2012-03-29 |
20120077833 | ACID ADDITION SALTS OF (3,5-BIS TRIFLUOROMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3YL-PYRIMIDIN-2YLAMINO)-PHENYL]- -BENZAMIDE - The present invention relates to acid addition salts of the pharmaceutically active compound (3,5-Bistrifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide(I): | 2012-03-29 |
20120077834 | Methods of Use of Cyclopamine Analogs - The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula: | 2012-03-29 |
20120077835 | FORMULATIONS OF RIFAXIMIN AND USES THEREOF - The present invention relates to new rifaximin forms comprising solid dispersions of rifaximin, methods of making same and to their use in medicinal preparations and therapeutic methods. | 2012-03-29 |
20120077836 | METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF - Disclosed are pharmaceutical compositions and methods for the administration of (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol or a pharmaceutically acceptable salt thereof and related compounds for the treatment of neurological disorder such as Parkinson's disease and restless leg syndrome. | 2012-03-29 |
20120077837 | ANTI-TUMOR AGENT - A combination therapy for tumor is provided. Disclosed is a method of treating tumor, the method comprises administering to a patient, a compound or pharmaceutically acceptable salt thereof represented by Formula (I) and everolimus represented by Formula (II): | 2012-03-29 |
20120077838 | Beta-2-Adrenoreceptor Agonists - Compounds of formula | 2012-03-29 |
20120077839 | SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUIN- OLIN-2-OL COMPOUNDS AND METHODS RELATING THERETO - Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1- | 2012-03-29 |
20120077840 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS - The present invention relates to novel heterocyclic compounds which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds. | 2012-03-29 |
20120077841 | METHODS FOR CANCER THERAPY AND STEM CELL MODULATION - The present invention relates to a method of modulating pluripotency and/or self-renewing characteristics of a stem/progenitor cell. The method comprises administering to the respective cell a compound of the general formula (I) | 2012-03-29 |
20120077842 | QUINOLINE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION - A pharmaceutical composition comprising a compound represented by the formula (I) or pharmaceutically acceptable salt thereof or solvate thereof; and a basic substance is excellent in dissolution, is stable even after a long term storage, and is useful as a preventive or therapeutic agent against a tumor: | 2012-03-29 |
20120077843 | MALIGNANT PRECURSOR CELLS FROM DUCTAL CARCINOMA IN SITU LESIONS - Described herein are progenitor cancer cells and cell lines isolated from human breast ductal carcinoma in situ (DCIS) lesions and the uses of these cells or cell lines in drug design, drug screening, and monitoring in vivo therapy. The DCIS malignant precursor cells or cell lines are epithelial in origin, are positive for markers of autophagy, show at least one genetic difference from normal cells of said fragment, form 3-D tube-like structures or ball aggregates, or are inhibited in formation of 3-D structures and migration by treatment with chloroquine. | 2012-03-29 |
20120077844 | USE OF PIPERIDINE DERIVATIVES AS DERMO-DECONTRACTING AGENTS - The present invention relates to a cosmetic process for treating wrinkled skin, in particular the skin of the face and/or of the forehead, through a dermo-decontracting effect, comprising the topical application to said skin of a composition comprising, in a physiologically acceptable medium, at least one piperidine derivative chosen from the compounds of formula (I): | 2012-03-29 |
20120077845 | ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF - The present invention relates to methods for reducing testosterone levels by reduction of luteinizing hormone (LH) or independent of LH levels in a male subject and methods of treating, suppressing, reducing the incidence, reducing the severity, or inhibiting prostate cancer, advanced prostate cancer, and castration-resistant prostate cancer (CRPC) and palliative treatment of prostate cancer, advanced prostate cancer and castration-resistant prostate cancer (CRPC). The compounds of this invention suppress free or total testosterone levels to castrate levels which may be used to treat prostate cancer, advanced prostate cancer, and CRPC without causing bone loss, decreased bone mineral density, increased risk of bone fractures, increased body fat, hot flashes and/or gynecomastia. | 2012-03-29 |
20120077846 | Treatment of renal cell carcinoma - Methods are provided of treating renal cancer by administration of certain 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide compounds, especially 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided. | 2012-03-29 |
20120077847 | ALPHA-KETOAMIDE DERIVATIVES USEFUL ENDOTHELIAL LIPASE INHIBITORS - The present invention is directed to α-ketoamide derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by endothelial lipase, for example, cardiovascular disorders. | 2012-03-29 |
20120077848 | NOVEL PROCESS TO PREPARE PIOGLITAZONE VIA SEVERAL NOVEL INTERMEDIATES - A novel process for preparing thiazolidinediones, preferably Pioglitazone, as described. Also described are novel intermediates involved in its synthesis and process for their preparation and use in medicine. | 2012-03-29 |
20120077849 | INHALER FOR DELIVERING A METERED DOSE - An inhaler for delivering a metered dose of a medicament, the inhaler comprising a dispensing port ( | 2012-03-29 |
20120077850 | PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION - Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone. | 2012-03-29 |
20120077851 | Urea Derivatives as Kinase Inhibitors - The present invention is directed to novel ureas, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R, R | 2012-03-29 |
20120077852 | HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS - The application of hydroxypyridonone in effective amounts as external agent for patients suffering from skin micro-circulatory disorders (SMD) provides for a significant amelioration of subject conditions. Accordingly, the new use of hydroxypyridonones as external anti-inflammatory agent thereby combined with the depletion of hemosiderin residues offers a suitable treatment to SMD sufferers. | 2012-03-29 |
20120077853 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 2012-03-29 |
20120077854 | COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4) - The present invention relates to compositions and methods for modulating retinol binding to retinol binding protein 4 (RBP4). In particular, the present invention provides compounds having Formula (1) or (2) (Formulae (1), (2)); wherein R | 2012-03-29 |
20120077855 | CRYSTALLINE TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS - The disclosure features crystalline tripeptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions. | 2012-03-29 |
20120077856 | PHARMACEUTICAL PRODUCT - An agent for suppressing the production of various cytokines (IL-8 and the like) and inflammatory mediators, an agent for suppressing the expression of COX-II and the like, or an inhibitor of various phosphorylation enzymes (ATF2 and the like), which contains a TLR signaling inhibitory substance, preferably a compound represented by the formula (I) or the formula (II) | 2012-03-29 |
20120077857 | INHIBITION OF INFLAMMATION BYSIMULTANEOUS BLOCKADE OF MULTIPLE PROSTANOID RECEPTORS - The present invention provides a method for treating inflammation in a patient in need thereof comprising administering to said patient an effective amount of a compound according to formula | 2012-03-29 |
20120077858 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE - The present invention provides compounds, that are N-alkyl-2-(1-(5-substituted-2-(3-oxo-3-(trifluoromethylsulfonamido)propyl)benzyl)pyrrolidin-2-yl)oxazole-4-carboxamide wherein the 5 substituent is selected from the group consisting of halo and alkyloxy radicals. The compound may be represented by the following formula | 2012-03-29 |
20120077859 | C-substituted Diindolylmethane Compositions and Methods for the Treatment of Multiple Cancers - The present embodiment of the invention is generally directed to compositions comprising suspensions of poorly water soluble compounds recrystallized in nanoparticulate sizes ranging from 0.1 to 5 μm. In addition, the embodiment of the invention is directed to methods for preparation and administration of these compositions to a patient for prevention and treatment of disease states. In particular, the embodiment of the invention is directed to compositions comprising suspensions of poorly water-soluble compounds, such as antimitotics and antibiotics, in nanoparticulates and methods of prevention and treatment of chronic disease states, such as cancer, by intraperitoneal and intravenous administration of such compositions. | 2012-03-29 |
20120077860 | Adeno-Associated Viral Vector for Exon Skipping in a Gene Encoding a Dispensable Domain Protein - The invention concerns an adeno-associated viral vector comprising:
| 2012-03-29 |
20120077861 | Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same - Bispecific antisense oligonucleotides which consist essentially of a sequence of bases that is complementary to portions of both the gene encoding human IGFBP-2 and the gene encoding human IGFBP-5 are useful in as antisense therapeutics in the treatment of endocrine-regulated cancers. | 2012-03-29 |
20120077862 | ANTISENSE MODULATION OF PTP1B EXPRESSION - Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided. | 2012-03-29 |
20120077863 | GUANIDINO-SUBSTITUTED BI-AND POLYPHENYLS AS SMALL MOLECULE CARRIERS - A compound of formula I, or a pharmaceutically acceptable salt thereof, wherein —X | 2012-03-29 |
20120077864 | RNAI-MEDIATED INHIBITION OF GREMLIN FOR TREATMENT OF IOP-RELATED CONDITIONS - RNA interference is provided for inhibition of gremlin in intraocular pressure-related conditions, including ocular hypertension and glaucoma such as normal tension glaucoma and open angle glaucoma. | 2012-03-29 |
20120077865 | METHODS FOR TREATING HYPERCHOLESTEROLEMIA - Disclosed herein are antisense compounds and methods for decreasing LDL-C in an individual having elevated LDL-C. Additionally disclosed are antisense compounds and methods for treating, preventing, or ameliorating hypercholesterolemia and/or atherosclerosis. Further disclosed are antisense compounds and methods for decreasing coronary heart disease risk. Such methods include administering to an individual in need of treatment an antisense compound targeted to a PCSK9 nucleic acid. The antisense compounds administered include gapmer antisense oligonucleotides. | 2012-03-29 |
20120077866 | ANTISENSE MODULATION OF C-REACTIVE PROTEIN EXPRESSION - Antisense compounds, compositions and methods are provided for modulating the expression of C-reactive protein. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding C-reactive protein. Methods of using these compounds for modulation of C-reactive protein expression and for treatment of diseases associated with expression of C-reactive protein are provided. | 2012-03-29 |
20120077867 | Compositions And Methods For Treating Pancreatic Cancer - The present invention provides a method of treating pancreatic cancer by inhibiting the activity cyclin D1 activity in tumor cells. The invention is based on the finding that cyclin D1 shRNA molecules are capable of attenuating tumor growth and interfering with tumor angiogenesis. | 2012-03-29 |
20120077868 | Use of Toll-like receptor-9 agonists, Toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of Toll-like receptor-4-associated disorders - The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis. | 2012-03-29 |
20120077869 | METHOD AND COMPOSITION USING A DUAL SPECIFICITY PROTEIN TYROSINE PHOSPHATASE AS AN ANTIMALARIAL DRUG TARGET - Phosphotyrosine phosphatase (PTP) encoded by PF13_0027 is a desirable drug target for the human malaria parasite | 2012-03-29 |
20120077870 | Materials and Methods for the Treatment of Pathological Neovascularization in the Eye - The subject invention provides materials and methods useful in safely and effectively preventing pathological proliferation of blood vessels. The prevention of the over-proliferation of blood vessels according to the subject invention is particularly advantageous for treatment of certain ocular conditions including age-related macular degeneration (AMD), retinopathy of prematurity (ROP) and diabetic retinopathy. In preferred embodiments, the subject invention provides materials and methods for effective treatment of pathological ocular neovascularization using gene therapy. In a specific embodiment the materials and methods of the subject invention can be used to treat AMD. | 2012-03-29 |
20120077871 | 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof - Provided herein are compounds, compositions containing the compounds, and methods for the treatment of cancer in a cancer patient. In particular, the compounds are made by a process comprising treating a first compound represented by either Formula G′ or Formula M′: | 2012-03-29 |
20120077872 | PRESERVATIVE-FREE PHARMACEUTICAL TETRAHYDROLIPSTATIN COMPOSITIONS - This invention refers to pharmaceutical compositions that comprise the mixture of an effective amount of leucine-derivative powders or granules and, at least, one pharmaceutically acceptable excipient substance used as carrier. In particular, the main feature of the pharmaceutical composition is the fact that it is free of preservative agents and might be formulated in any usual pharmaceutical oral formulation. | 2012-03-29 |
20120077873 | Methods of Reducing Blood Lactate Concentration - The present invention is directed to methods for reducing blood lactate concentration during exercise, physical activity or athletic performance. | 2012-03-29 |
20120077874 | DEVELOPMENT OF A PHYTOESTROGEN PRODUCT FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS USING RED CLOVER - A phytoestrogen blend was developed using a pharmaceutical platform technology to identify the time course of active components and effect time course of these components in the biophase after administration of a red clover extract. This phytoestrogen blend consists of biochanin A, daidzein, equol and genistein. The recommended daily dosage ranges from 5 to 200 mg of total isoflavone. | 2012-03-29 |
20120077875 | COMPOSITION INCLUDING AT LEAST ONE TRANS-CINNAMALDEHYDE AND THE USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS, SPECIFICALLY IN THE TREATMENT OF NOSOCOMIAL INFECTIONS - The present invention relates to a composition, in particular an antibacterial drug, including trans-cinnamaldehyde, a pharmaceutical composition including trans-cinnamaldehyde for treatment or prevention, in particular, of a nosocomial infection, specifically caused by a bacteria resistant to anti-bacterial drugs, the use of trans-cinnamaldehyde as an anti-bacterial agent and a method for preparing a surface including the application of a composition according to the invention. | 2012-03-29 |
20120077876 | Method For Improved Bioactivation Of Pharmaceuticals - This invention relates to a prodrug comprising a partial structure having the general formula (I) or (II), where R | 2012-03-29 |
20120077877 | MEDIUM CHAIN PEROXYCARBOXYLIC ACID COMPOSITIONS - The present invention relates to compositions including medium chain peroxycarboxylic acid, methods for making these compositions, and methods for reducing the population of a microorganism. The compositions can include advantageously high levels of the medium chain peroxycarboxylic acid, can be readily made, and/or can exhibit reduced odor. | 2012-03-29 |
20120077878 | GASTRIC RETENTIVE DOSAGE FORMS FOR EXTENDED RELEASE OF ACAMPROSATE INTO THE UPPER GASTROINTESTINAL TRACT - Gastric retentive dosage forms for sustained release of acamprosate are described which may allow once- or twice-daily dosing for both acute and long-term treatment of a disorder including alcohol dependence, tinnitus, sleep apnea, Parkinson's disease, levodopa-induced dyskinesias in Parkinson's disease, Alzheimer's disease, Huntington's disease, Amyotrophic lateral sclerosis, Cortical spreading depression, migraine, schizophrenia, anxiety, tardive dyskinesia, spasticity, multiple sclerosis, various types pain, or binge eating. Methods of treatment using the dosage forms and methods of making the dosage forms are also described. | 2012-03-29 |
20120077879 | Process for making compositions with poorly compressible therapeutic compounds - A process for preparing solid dosage forms that contain poorly compressible therapeutic compound. The process, for example, provides for the inventive use of an extruder, especially a twin screw extruder, to melt granulate a therapeutic compound(s) with a granulation excipient. | 2012-03-29 |
20120077880 | Highly Concentrated, Spherical Biopolymer Gel Particle Suspensions Prepared by HIPE-Gelation Process - The invention relates to highly concentrated, spherical, biopolymer gel particle suspensions comprising particle of defined particle diameter range (e.g., 1 to 50μ) and process for preparing the suspensions utilizing high internal phase emulsion as intermediate. | 2012-03-29 |
20120077881 | HIPE-Gelation Process for Making Highly Concentrated, Spherical Biopolymer Gel Particle Suspensions - The invention relates to process for making highly concentrated, spherical biopolymer gel particle suspensions comprising particles of defined particle diameter (e.g., range of 1 to 50μ) utilizing high internal phase emulsion as an intermediate. | 2012-03-29 |
20120077882 | ANTIBACTERIAL AGENT-COMPRISING POWDERS AND METHODS FOR MANUFACTURING THE SAME - Skin and surface sanitizers and methods for forming skin and surface sanitizers are provided. In one embodiment, a surface sanitizer is formed of a plurality of dry particles. Each dry particle comprises a liquid comprising an antibacterial agent and a dry particulates coating surrounding the liquid. The liquid is present in an amount of from about 10 to about 90 wt. % of each dry particle. The surface sanitizer has a germ kill effectiveness of at least 50%. | 2012-03-29 |
20120077883 | TREATMENT OF TINNITUS AND ASSOCIATED AUDITORY DYSFUNCTIONS - The invention provides cyclobenzaprine for use in the treatment of tinnitus and related auditory dysfunctions by oral administration as tablets, capsules, powder or a solution or by parenteral administration of cyclobenzaprine through intramuscular, intravenous, subcutaneous or intrathecal injection, or infusion, preferably in an amount from 15 to 45 mg/day, preferably in a long-term treatment over 2 or 8 weeks or more. | 2012-03-29 |
20120077884 | COCCIDIOSIS CONTROLLING AGENT AND FEED CONTAINING THE SAME - An object of the present invention is to provide: a coccidiosis controlling agent which is excellent in safety, is free of problems such as side-effects, does not cause effect reduction or the like due to the acquisition of resistance to a medicament, and exhibits a high preventive effect and a high treatment effect against coccidiosis; a feed for an animal containing the anticoccidial composition; and a method for raising an animal using the coccidiosis controlling agent and the feed. In order to solve the above-mentioned problem, provided is a coccidiosis controlling agent for an animal, containing heated cashew nut shell liquid and/or cardanol. | 2012-03-29 |
20120077885 | GELLING AGENT AND GEL - A compound represented by the following formula (1) is provided as a gelling agent for gelatinizing a liquid organic compound: | 2012-03-29 |
20120077886 | HYDROPHILIC POLYPROYLENE MELT ADDITIVES - Melt additive ionic and non-ionic surfactants to impart stable durable hydrophilicity to thermoplastic polymers or blends thereof. | 2012-03-29 |
20120077887 | TERPOLYMERS AS PRESSURE-SENSITIVE ADHESIVES - Disclosed herein are terpolymers that can function as pressure-sensitive adhesives. The disclosed articles comprise the terpolymers adhered to a release liner. The disclosed implant devices comprise the pressure-sensitive adhesive terpolymer adhered to a surface thereof. The pressure-sensitive adhesive terpolymer can promote adhesion of the implant device to a location in a subject. | 2012-03-29 |
20120077888 | ORODISPERSIBLE TABLETS - A directly compressed orodispersible tablet comprises 0.1 to 50% of a ungranulated active agent (w/w), 10 to 80% of a sugar-based direct compression base, and 10 to 80% of a microcrystalline cellulose (MCC) direct compression base, and has a hardness of at least 60N, and a disintegration time of less than 40 seconds. The sugar-based direct compression base is a DC sugar alcohol, especially direct compression mannitol, and the MCC base is a silicified MCC, especially a Prosolv. The active is a hydrophobic active, typically a high-dose active. Also disclosed is a method of producing an orodispersible tablet comprising the steps of directly compressing a mixture of components at a compression force of at least 5 k N to form the tablet, wherein the mixture of components comprises 0.1 to 50% of an active agent (w/w), 10 to 80% of a sugar-based direct compression base (w/w); and 10 to 80% of a microcrystalline cellulose (MCC) direct compression base (w/w). | 2012-03-29 |
20120077889 | APPARATUS AND METHOD FOR PRODUCING THERMOPLASTIC ELASTOMER, ELASTOMERS PRODUCED THEREBY AND ARTICLES PRODUCED FROM THE ELASTOMERS - A method for producing thermoplastic elastomer is disclosed and comprises the step of: blending a mixture including particles of vulcanized rubber material and a molten thermoplastic material such that the rubber material is subjected to mechanical shearing forces and the surfaces of the rubber particles undergo homolytic bond scission to form chains of free radicals which cross-link with the thermoplastic material. Apparatus for carrying out the method, elastomers produced by the method and articles produced from the elastomers are also disclosed. | 2012-03-29 |
20120077890 | Composite Building Materials and Methods of Manufacture - A composite building material includes carpet waste having carpet fibers and adhesive, and an inorganic filler that includes fly ash. The composite building material may be produced by providing the carpet waste, mixing the carpet waste with the inorganic filler to produce a homogeneous blend, and forming the homogeneous blend into the composite building material. The composite building material may optionally include a base polymer, slack wax, and/or calcium carbonate. | 2012-03-29 |
20120077891 | POROGEN COMPOSITIONS, METHODS OF MAKING AND USES - Provided are porogen compositions and methods of using such porogen compositions in the manufacture of porous materials, for example, porous silicone elastomers. The porogens generally include comprising a core material and shell material different from the core material. The porogens can be used to form a scaffold for making a resulting porous elastomer when the scaffold is removed. | 2012-03-29 |
20120077892 | METHOD AND SEALANT FOR SEALING AIR FILTER LEAKS - The present invention relates generally to a patch including a micro fiber glass and a polymeric binder, where the mixture forms an in situ porous patch that allows for active filtration after application to a leak or hole in an air filter. The mixture can be pressurized with a propellant within a housing prior to application to a leak or hole in an air filter. The mixture can also be applied manually to a leak or hole in an air filter, without the need to be pressurized with a propellant within a housing. | 2012-03-29 |
20120077893 | Premixes Suitable for the Production of Membrane Materials - Premixes suitable for the production of membrane materials are described. Products of this invention are suitable for the formation of membranes and membrane modules that may be in the form of flat sheets, tubes, or hollow fibers. | 2012-03-29 |
20120077894 | EXTRUDED POLYMER FOAMS CONTAINING BROMINATED FATTY ACID-BASED FLAME RETARDANT ADDITIVES - Extruded polymer foams are prepared using brominated fatty acids, an ester, amide or ester-amide of a brominated fatty acid, a glyceride of one or more brominated fatty acids, or a polymerized brominated fatty acid as an FR additive. The brominated FR additives unexpectedly are stable at the extrusion temperatures, and provide excellent flame retardancy to the foams. | 2012-03-29 |
20120077895 | STATUS ESTIMATION DEVICE, STATUS ESTIMATION METHOD AND PROGRAM FOR ULTRAVIOLET CURABLE RESIN - A status estimation device for ultraviolet curable resin includes a probe configured to irradiate an ultraviolet curable resin with excitation light, a wavelength demultiplexer configured to receive fluorescence produced from the ultraviolet curable resin and detect spectral distribution of the fluorescence, and a computer configured to estimate status of the ultraviolet curable resin by comparing a shape of pre-irradiation spectral distribution detected when the ultraviolet curable resin is irradiated by excitation light before being irradiated by ultraviolet radiation with a shape of post-irradiation spectral distribution detected when the ultraviolet curable resin is irradiated by excitation light after being irradiated by ultraviolet radiation. | 2012-03-29 |
20120077896 | ACTIVE ENERGY RAY CURABLE-TYPE INKJET RECORDING INK COMPOSITION - The object to be achieved by the present invention is to provide an active energy ray curable-type inkjet recording ink composition that is used for recording on a glass surface and is excellent in adhesiveness to the glass surface and water resistance and alcohol resistance. The active energy ray curable-type inkjet recording ink composition of the present invention at least contains: (b) photopolymerization initiator; 40 to 75 percent by mass of (d) cyclic monofunctional (meth)acrylate; 5 to 20 percent by mass of (e) hydroxyl group-containing (meth)acrylate; and 3 to 10 percent by mass of (c) epoxy group-containing silane coupling agent. The active energy ray curable-type inkjet recording ink composition is used for recording on a glass surface. | 2012-03-29 |
20120077897 | Black Photosensitive Resin Composition and Light Blocking Layer Using the Same - Disclosed are a black photosensitive resin composition that includes (A) an organic binder resin, (B) a reactive unsaturated compound, (C) a photopolymerization initiator, (D) a black pigment including carbon black and a silver-tin-containing alloy, and (E) a solvent, and a light blocking layer using the same. | 2012-03-29 |
20120077898 | Crosslinked Polyolefin Polymer Blends - Crosslinked polyolefin blends, methods for their production, and articles made of the same are provided. In at least one specific embodiment, the polyolefin blends comprise a first polymer formed in a first reactor and a second polymer formed in a second reactor. The first and second polymers, as well as the resulting blend, may comprise units derived from propylene, ethylene, and a diene. The blended composition can then be compounded with one or more coagents, antioxidants, UV sensitizers, and/or other additives and crosslinked, preferably by exposure to UV radiation and/or energetic photons. The crosslinked polymers are particularly useful for making fibers, films, and nonwovens. | 2012-03-29 |
20120077899 | PREPARATION OF FUNCTIONAL STAR MACROMOLECULES - A process for constructing multi-arm star macromolecules with uniform properties, high molecular weight and narrow molecular weight distribution using free radical polymerization is described. | 2012-03-29 |
20120077900 | Polyether Group Containing Dental Composition Containing An F-Containing Compound, Process of Production and Use Thereof - The invention relates to a curable dental composition comprising a curable polyether group containing polymer as component (A), an initiator capable of initiating a curing reaction of component (A) as component (B) and a certain F-containing compound as component (C). The invention also relates to a method of production and use of the curable dental composition or a respective kit of parts for the preparation of or as impression material or for the preparation of crowns and bridges. | 2012-03-29 |
20120077901 | DENTAL GLASS IONOMER CEMENT COMPOSITION - To provide a dental glass ionomer cement composition having excellent adhesion strength to a metallic prosthesis. A dental glass ionomer cement composition includes a copolymer (A), a fluoroaluminosilicate glass powder (B) and water (C). The copolymer (A) includes a polymer or copolymer of α-β unsaturated carboxylic acid, or includes a copolymer of α-β unsaturated carboxylic acid and one or more kinds selected from a group of acrylamide, acrylonitrile, methacrylic acid ester, acrylates, vinyl chloride, allyl chloride and vinyl acetate. In the copolymer (A), the number of molecules of α-β unsaturated carboxylic acid occupies 50% or more of the total number of molecules. The dental glass ionomer cement composition further includes a compound (D) which contains a sulfur atom in one molecule, includes a carboxylic group and an amino group and does not include a polymerizable group. | 2012-03-29 |
20120077902 | PNEUMATIC TIRE - The invention is directed to a pneumatic tire having a tread comprising a vulcanizable rubber composition comprising, expressed as parts by weight per 100 parts by weight of elastomer (phr),
| 2012-03-29 |
20120077903 | EPOXY RESIN-BASED COATING COMPOSITION - The present invention relates to epoxy resin coating composition which comprises, at least, epoxy resin, a thiol-type curing agent and a curing assistant, being composed of two liquids of liquid (A) containing epoxy resin and a thiol-type curing agent and liquid (B) containing a curing assistant, which liquids are mixed just before using, wherein the thiol-type curing agent contains a branched compound containing a thiol group (P), which compound is an ester of polyhydric alcohol with thiol group-containing carboxylic acid represented by formula (1) | 2012-03-29 |
20120077904 | Epoxy Resin Composition - The present invention provides an epoxy resin composition comprising epoxy resin, phenolic resin, a cure accelerator and an inorganic filler; said epoxy resin comprises: (1) 20-50% of Formula I; (2) 10-40% of Formula II; and (3) 0-30% of Formula III and/or 0-40% of Formula IV, wherein Formula III and Formula IV are not 0% simultaneously; and wherein, R | 2012-03-29 |
20120077905 | Biodegradable Polymer Composition - The invention relates to a biodegradable polymer composition comprising the following components (a)-(f) and/or product(s) formed from a reaction between the components: (a) one or more biodegradable polyesters; (b) polysaccharide; (c) polymer having pendant carboxylic acid groups; (d) transesterification catalyst; (e) polyepoxide; and (f) fatty acid sodium salt. | 2012-03-29 |
20120077906 | Flexible Watertight Roof Coatings - The invention provides for the use of coating compositions based on one or more mineral binders, one or more polymers, one or more fillers, and, if desired, one or more additives for producing roof coatings, the coating compositions comprising at least 50% by weight of polymers, based on the dry weight of the polymers and of the mineral binders. | 2012-03-29 |
20120077907 | STYRENE-BUTADIENE BASED REDISPERSIBLE POLYMER POWDERS WITH IMPROVED STABILITY IN CEMENT APPLICATIONS - A water redispersible polymer powder is produced by drying an aqueous mixture of a carboxylated styrene butadiene polymer and a colloidal stabilizer which includes a polyvinyl alcohol modified with an alkyl end chain. The alkyl modified polyvinyl alcohol provides excellent redispersibility of the redispersible polymer powder without adversely affecting spray drying. Cement compositions such as mortars, which contain the redispersible polymer powder with the alkyl modified polyvinyl alcohol exhibit unexpectedly superior stability and an unexpectedly lower rate of mortar viscosity buildup which is advantageous for workability or troweling. | 2012-03-29 |
20120077908 | Method for the Production of Wood Material Articles with Low Emissions of Chemical Compounds - The invention relates to a method for production of wood material articles with low emissions of chemical compounds. The applied wood is treated with bisulfite before bonding. On using formaldehyde resins in the bonding agent, wood material articles can be produced with the inventive method with extremely low formaldehyde emissions and very bright colours. | 2012-03-29 |
20120077909 | ELECTRICALLY NEUTRAL DISPERSIONS AND METHOD OF PREPARING SAME - The invention is a method of producing an essentially electrically neutral polymer dispersion, comprising a polymerizing one or more monomers in the presence of a nonionic surfactant, wherein the polymerization preferably occurs in the absence of ionic surfactants. The invention also includes methods of producing positively or negatively charged polymer dispersions comprising producing the essentially nonionic polymer dispersion and further adding a cationically-charged or anionically-charged surfactant or electrolyte. The invention further includes dispersions produced by the methods of the invention and polymer films and powders produced from these dispersions. | 2012-03-29 |
20120077910 | FLAME RETARDANT RESIN COMPOSITION AND MOLDED ARTICLE THEREOF - It is a purpose of the present invention to provide a flame retardant resin composition having a high level of flame retardancy and excellent physical properties and a molded article thereof. | 2012-03-29 |
20120077911 | AQUEOUS COATING MATERIAL AND PAINTED ARTICLE - The present invention relates to an aqueous coating material containing polymer (I), colloidal silica (II), and nonionic surfactant (III) with an HLB value of 16 or more. The polymer (I) is obtained by copolymerization of monomer mixture (M) that contains 0.2 to 10% by mass of monomer (a) having two or more radically polymerizable groups. The solid content of the colloidal silica (II) is 0.1 to 20 parts by mass with respect to 100 parts by mass of the polymer (I). The content of the nonionic surfactant (III) is 0.01 to 10 parts by mass with respect to 100 parts by mass of the polymer (I). The present invention also relates to a painted article where the aqueous coating material is applied. Therefore, an aqueous coating material and a painted article capable of expressing stain resistance and weather resistance can be provided by reducing a water contact angle. | 2012-03-29 |
20120077912 | POLYESTER HAVING RENEWABLE 1,3-PROPANEDIOL - The present disclosure is directed to a polyester having renewable 1,3-propanediol. This invention is further directed to a coating composition comprising the polyester having components derived from renewable resources. | 2012-03-29 |
20120077913 | TRI-COMPONENT RESINS FOR PIGMENTED INK - A solid ink that includes an ink carrier and a resinous compound of the formulas | 2012-03-29 |
20120077914 | NOVEL PLASTICIZER FOR A POLYVINYL CHLORIDE RESIN - The present invention relates to an ester compound using alicyclic polyhydric acid and to a plasticizer for plastics, particularly, polyvinylchloride (PVC), including the ester compound More particularly, the present invention relates to a plasticizer, which is derived by the esterification reaction of alicyclic polyhydric acid and alcohol. When a polyvinylchloride resin is manufactured using the plasticizer, there are advantages in that the obtained products are excellent in terms of plasticizing efficiency, and in that their physical properties, such as hardness, tensile strength and the like, can be improved. | 2012-03-29 |
20120077915 | AQUEOUS FLUORORESIN DISPERSION AND METHOD FOR PRODUCING THE SAME - The present invention provides an aqueous fluororesin dispersion comprising a melt-processable fluororesin which is low in fluorinated surfactant concentration and excellent in dispersion stability even when the concentration of the melt-processable fluororesin is high. The present invention is related to an aqueous fluororesin dispersion comprising a melt-processable fluororesin particle dispersed in an aqueous medium, wherein a concentration of the melt-processable fluororesin is 55 to 75% by mass relative to the aqueous fluororesin dispersion, and a fluorinated surfactant content in the aqueous fluororesin dispersion is not higher than a level corresponding to 100 ppm of the melt-processable fluororesin. | 2012-03-29 |
20120077916 | Pressure Sensitive Adhesive Soluble in Acetone - An emulsion polymerization copolymer comprising 59-77 phr butadiene, 10-16 phr styrene; 10-16 phr acrylonitrile; and from 3-9 phr methacrylic acid is soluble in acetone for U.S. EPA-exempt, low-VOC emissions, while also soluble in toluene. The composition is formulated with a tackifying resin; a plasticizer oil; and a U.S. EPA-exempt solvent, preferably acetone, to make an adhesive. The formulation is particularly useful as a pressure sensitive adhesive for tape and for making shoes. | 2012-03-29 |
20120077917 | METHOD FOR DRY GRINDING A MATERIAL CONTAINING A CARBONATE ORE - The present invention provides a product obtained by a method of dry milling a mineral material in at least one milling unit: (i) in the presence of at least one polyalkylene glycol polymer having monomer units forming a backbone, where at least 90% of the monomer units forming the backbone of the polymer are constituted by ethylene oxide, propylene oxide or their mixtures, and where the polymer has a molecular weight of at least equal to 400 g/mole, and (ii) in a quantity of water that is less than 10% in dry weight of the material in the milling unit. | 2012-03-29 |
20120077918 | MIXTURES CONTAINING EFFECTIVE MATERIALS AND INORGANIC COMPOUNDS WITH HIGH SURFACE AREA - Mixtures comprising inorganic compounds and effect substances, where the inorganic compounds are present as agglomerates and these agglomerates have a specific surface area greater than 10 m | 2012-03-29 |
20120077919 | THERMOPLASTIC POLYOLEFIN COMPOUNDS WITH DECREASED FLAMING SENSITIVITY - Thermoplastic polyolefin compounds for the production of injection moulded, paintable and flame pre-treatable articles comprising A) 50 wt % to 90 wt % of a propylene homo- or copolymer matrix phase (M) and B) 10 wt % to 50 wt % of a first elastomer comprising an ethylene-C | 2012-03-29 |
20120077920 | MOLDED ELASTOMER FOR ENDOSCOPE - A molded elastomer for an endoscope is provided, which includes a fluorine-containing elastomer and a filler. The filler includes thermal black in a content of 1 to 10 parts by mass based on 100 parts by mass of the fluorine-containing elastomer, and plate alumina in a content of 2 to 10 parts by mass based on 100 parts by mass of the fluorine-containing elastomer. | 2012-03-29 |
20120077921 | UNSATURATED POLYESTER RESIN COMPOSITION AND ENCAPSULATED MOTOR - Provided is an unsaturated polyester resin composition comprising 100 parts by mass of an unsaturated polyester resin (a) 400 to 1,000 parts by mass of a mixture of an inorganic filler (b) having a thermal conductivity coefficient of 20 W/m·K or more and aluminum hydroxide (c); 20 to 300 parts by mass of a glass fiber (d) having a fiber length of 1.5 mm or less; and 15 to 50 parts by mass of a low profile additive (e), the inorganic filler (b) and the aluminum hydroxide (c) being mixed at a mass ratio of 80:20 to 20:80, in which the unsaturated polyester resin composition further includes an alkyl peroxyalkylate-based curing agent (f) represented by the following formula (1): | 2012-03-29 |
20120077922 | Amino Alkoxy-Modified Silsesquioxane Adhesives For Improved Metal Adhesion And Metal Adhesion Retention To Cured Rubber - Amino alkoxy-modified silsesquioxanes (amino AMS), and/or amino co-AMS compounds that also comprise a mercaptosilane or a blocked mercaptosilane, are excellent adhesives for coating plated or unplated metal wire for adherence of the wire to a rubber stock. The amino AMS and/or the amino/mercaptan co-AMS adhesives can be used with all types of rubber and there is no requirement for the use of special adhesive additives to the rubber vulcanizates, such as, but not limited to, cobalt, resins and high sulfur levels. In particular, the use of amino AMS and/or amino/mercaptan co-AMS compounds as adhesives for bonding wire to rubber also improves the adherence performance of the reinforcements to obtain sufficient bonding that is resistant to degradation over the course of time, especially resistance to thermal aging and/or thermo-oxidizing aging, in particular corrosion in the presence of water. Vulcanized rubber compositions that contain an amino AMS and/or amino/mercaptan co-AMS compound also have improved adhesion to embedded uncoated steel after humidity aging compared with vulcanized rubber compositions not containing the amino alkoxy-modified silsesquioxane. | 2012-03-29 |
20120077923 | FUNCTIONAL FLUID COMPOSITIONS WITH IMPROVED SEAL SWELL PROPERTIES - A functional fluid composition comprising: (a) from 70% to 99.99%, by weight of the fluid composition, of a base oil composition comprising: (i) from 50% to 95%, by weight of the base oil composition, of a naphthenic base oil; and (ii) from 5% to 50%, by weight of the base oil composition, of a Fischer-Tropsch derived base oil. The functional fluid compositions according to the present invention are suitable for use in hydraulic fluids and shock absorber fluids and are useful for reducing the volume swell of synthetic rubbers. | 2012-03-29 |
20120077924 | FLUORORUBBER MOLDED ARTICLE - To provide a fluororubber formed product having excellent heat resistance and excellent mechanical properties at high temperatures. | 2012-03-29 |
20120077925 | SEALING MATERIAL - To provide a sealing material which is excellent in sealability under high-temperature conditions as well as crack resistance at high temperatures and high compression. A sealing material comprising a cross-linked fluororubber layer obtainable by cross-linking a fluororubber composition containing a fluororubber (A) and a carbon black (B), the cross-linked fluororubber layer having a loss modulus E″ of 600 kPa or higher and 6,000 kPa or lower determined by a dynamic viscoelasticity test under conditions of measurement temperature: 160° C., tensile strain: 1%, initial force: 157 cN, and frequency: 10 Hz. | 2012-03-29 |
20120077926 | METHOD FOR PRODUCING FLUORORUBBER COMPOSITION - The present invention provides a method for producing a fluororubber composition that has excellent heat resistance and excellent mechanical properties at high temperatures. The production method comprises the step of mixing a fluororubber (A) and a carbon black (B) in the presence of an organic amine compound (C1) and/or an acid acceptor (C2) to prepare a mixed product, wherein the mixed product has a highest temperature Tm of 80° C. to 220° C. while being mixed and has a highest temperature of 80° C. to 220° C. upon being discharged. | 2012-03-29 |
20120077927 | FLUORORUBBER COMPOSITION - The present invention provides a fluororubber composition that has excellent heat resistance and excellent mechanical properties at high temperatures. The fluororubber composition comprises 100 parts by mass of a peroxide cross-linkable fluororubber (A); 5 to 50 parts by mass of a carbon black (B); 0.1 to 10 parts by mass of a peroxide cross-linking agent (C); and 10 parts by mass or smaller of a bisolefin (D). | 2012-03-29 |
20120077928 | Polymerization using a diallylamine and a compound comprising a macromolecular chain comprising units derived from this amine - Compounds containing macromolecular chains and having a structured architecture are prepared by polymerization of macromolecular monomers containing diallylamine structural units. | 2012-03-29 |
20120077929 | POLYTRIMETHYLENE ETHER-BASED POLYURETHANE IONOMERS - Disclosed is aqueous polyurethane dispersion with a polyurethane having a polymeric backbone with ionic and/or ionizable functionality incorporated into the polymeric backbone. The polymeric backbone consists essentially of one or more non-ionic segments derived from a reaction product of polytrimethylene ether glycol and a diisocyanate. The manufacture of such polyurethanes is also disclosed. | 2012-03-29 |
20120077930 | MOLD-RELEASING AGENT - Disclosed is a mold-releasing agent comprising, as active ingredients, a graft copolymer (A) in which a polyalkylene glycol or an alkyl ether thereof is graft-copolymerized with a polyfluoro-1-alkene represented by the general formula: C | 2012-03-29 |